JTX-1484

N/A

Report date: 2024/09/14 10:21:10

Base Information

Drug NameJTX-1484
Drug Alias NameJTX-1484
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-Leukocyte immunoglobulin-like receptor subfamily B member 4
TargetsLeukocyte immunoglobulin-like receptor subfamily B member 4
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesJounce Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesJounce Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A